ARDELYX, INC. Stock Issued During Period, Shares, New Issues
ARDELYX, INC. (ARDX) reported Stock Issued During Period, Shares, New Issues of 8.20 million shares for the 8-month period ending 2021-02-28, per its 10-K filed 2021-03-08.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2021-03-08
- 2021-02-28: Stock Issued During Period, Shares, New Issues 8 month 8.20M shares.
- 2020-12-31: Stock Issued During Period, Shares, New Issues 6 month 3.30M shares.
- 2016-01-31: Stock Issued During Period, Shares, New Issues 1 month 8.63M shares.
- 2015-06-30: Stock Issued During Period, Shares, New Issues 1 month 7.24M shares.
| Period end | Stock Issued During Period, Shares, New Issues 1 month | Stock Issued During Period, Shares, New Issues 6 month | Stock Issued During Period, Shares, New Issues 8 month |
|---|---|---|---|
| 2021-02-28 | 8.20M shares 10-K · filed 2021-03-08 | ||
| 2020-12-31 | 3.30M shares 10-K · filed 2021-03-08 | ||
| 2016-01-31 | 8.63M shares 10-Q · filed 2016-11-07 | ||
| 2015-06-30 | 7.24M shares 10-Q · filed 2017-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |